ELECSYS AMH
Received Oct 19, 2022 · Event occurred Sep 8, 2022
Report 1823260-2022-03255 · MDR key 15633181
Device
Generic name
Anti-müllerian Hormone Test System
Manufacturer
Roche DiagnosticsModel number
NACatalog number
07026714190
Lot number
58177701
Product problems
- Low Test Results
- Non Reproducible Results
- Low Test Results
- Non Reproducible Results
Patient
Female
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
THE LAST CALIBRATION PERFORMED ON 14-AUG-2022 WAS WITHIN SPECIFICATIONS. THE QC RECOVERY WAS WITHIN -2SD AND WITHIN SPECIFICATIONS. THERE IS NO INDICATION OF A PERFORMANCE ISSUE WITH THE REAGENT. THE CUSTOMER SENT OUT NEW SAMPLES FOR FURTHER COMPARISON TESTING AND FOUND THEM ALL TO BE WITHIN THEIR LABORATORY'S ACCEPTABLE LIMITS. AFTER THE INSTRUMENT'S PERFORMANCE WAS VERIFIED, NO FURTHER ISSUES WERE REPORTED BY THE CUSTOMER. THE INVESTIGATION DETERMINED THE ISSUE WAS RESOLVED. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.
Additional Manufacturer Narrative
THE FIELD SERVICE ENGINEER (FSE) INSPECTED THE ANALYZER AND DID NOT FIND ANY HARDWARE ISSUES. HE THEN PERFORMED AN INSTRUMENT CHECK WITH ACCEPTABLE RESULTS. HE DID NOT PERFORM ANY REPAIRS. THE CUSTOMER PERFORMED QC WITH ACCEPTABLE RESULTS. THE ANALYZER'S PERFORMANCE WAS VERIFIED.
Description of Event or Problem
THE INITIAL REPORTER RECEIVED QUESTIONABLE ELECSYS AMH (AMH) RESULTS FOR TWO PATIENT SAMPLES TESTED ON THE COBAS E 801 ANALYTICAL UNIT WITH SERIAL NUMBER (B)(4). THE INITIAL RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE REPORTER WAS PERFORMING A QC INVESTIGATION FOR LOW BIAS OF THE AMH ASSAY. THE REPORTER USED OLD PROFICIENCY MATERIAL FOR REPEATS AND IT WAS CONFIRMED THAT THERE WAS A LOW BIAS. THE REPORTER THEN SENT OUT THE PATIENT SAMPLES TO A LABORATORY THAT USES A ROCHE ELECSYS ANALYZER FOR A SPLIT-SAMPLE ANALYSIS. PATIENT 1: THE INITIAL RESULT FROM THE ANALYZER WAS 6.83 NG/ML. THE REPEAT RESULT FROM THE OTHER LABORATORY WAS 11.61 NG/ML. PATIENT 2: THE INITIAL RESULT FROM THE ANALYZER WAS 12.1 NG/ML. THE REPEAT RESULT FROM THE OTHER LABORATORY WAS 35.3 NG/ML. THE REPEAT RESULTS WERE DEEMED CORRECT.